Mrzljak, A., Cigrovski Berković, M., Giovanardi, F. & Quirino, L. (2022). The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis. Croatian Medical Journal, 63. (2), 176-186. doi: 10.3325/cmj.2022.63.176
Mrzljak, Anna, et al. "The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis." Croatian Medical Journal, vol. 63, no. 2, 2022, pp. 176-186. https://doi.org/10.3325/cmj.2022.63.176
Mrzljak, Anna, Maja Cigrovski Berković, Francesco Giovanardi and Lai Quirino. "The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis." Croatian Medical Journal 63, no. 2 (2022): 176-186. https://doi.org/10.3325/cmj.2022.63.176
Mrzljak, A., et al. (2022) 'The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis', Croatian Medical Journal, 63(2), pp. 176-186. doi: 10.3325/cmj.2022.63.176
Mrzljak A, Cigrovski Berković M, Giovanardi F, Quirino L. The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis. Croatian Medical Journal [Internet]. 2022 April 30 [cited 2024 October 07];63(2):176-186. doi: 10.3325/cmj.2022.63.176
A. Mrzljak, M. Cigrovski Berković, F. Giovanardi and L. Quirino, "The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis", Croatian Medical Journal, vol. 63, no. 2, pp. 176-186, April 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:823316. [Accessed: 07 October 2024]